| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/00498254.2017.1295171 |
| P698 | PubMed publication ID | 28281384 |
| P2093 | author name string | John Davis | |
| Bing Zhu | |||
| Phi Tran | |||
| Imad Hanna | |||
| Arpine Vapurcuyan | |||
| Adrienne Natrillo | |||
| Matthew H Crouthamel | |||
| Natalya Alexander | |||
| P2860 | cites work | A plasma concentration of α-ketoglutarate influences the kinetic interaction of ligands with organic anion transporter 1. | Q39000910 |
| Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics | Q39398250 | ||
| Investigation of the inhibitory effects of various drugs on the hepatic uptake of fexofenadine in humans | Q40027645 | ||
| Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers | Q40098479 | ||
| Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans | Q40290148 | ||
| Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans | Q40293110 | ||
| Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans | Q40398090 | ||
| Disposition and metabolism of [(14)C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects | Q40877863 | ||
| Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins | Q42113514 | ||
| Pharmacokinetics of valsartan in patients with liver disease | Q42665290 | ||
| A membrane vesicle-based assay to enable prediction of human biliary excretion | Q44175425 | ||
| Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models | Q46063158 | ||
| Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption | Q46502784 | ||
| Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study. | Q48381282 | ||
| Effects of rhinacanthin-C on function and expression of drug efflux transporters in Caco-2 cells. | Q50931024 | ||
| In vitro and clinical evaluation of OATP-mediated drug interaction potential of sacubitril/valsartan (LCZ696). | Q51694525 | ||
| Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects. | Q54194794 | ||
| Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide | Q22253972 | ||
| Angiotensin-neprilysin inhibition versus enalapril in heart failure | Q28247091 | ||
| The human bile salt export pump: characterization of substrate specificity and identification of inhibitors | Q28612066 | ||
| Predicting in vivo drug interactions from in vitro drug discovery data | Q31011412 | ||
| Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans | Q34322618 | ||
| Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system | Q34403502 | ||
| Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization | Q34413813 | ||
| Drug-drug interaction between pitavastatin and various drugs via OATP1B1. | Q34566306 | ||
| Reduced cellular accumulation of topotecan: a novel mechanism of resistance in a human ovarian cancer cell line | Q36292082 | ||
| Breast cancer resistance protein in pharmacokinetics and drug-drug interactions | Q36544862 | ||
| Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation | Q36736998 | ||
| Growth hormone treatment of premature ovarian failure in a mouse model via stimulation of the Notch-1 signaling pathway | Q37001887 | ||
| Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction. | Q37412804 | ||
| BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs | Q38640797 | ||
| Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III. | Q38962542 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 300-313 | |
| P577 | publication date | 2017-03-10 | |
| P1433 | published in | Xenobiotica | Q1360678 |
| P1476 | title | Transport properties of valsartan, sacubitril and its active metabolite (LBQ657) as determinants of disposition. | |
| P478 | volume | 48 |
| Q103016954 | Drug-Drug Interaction Surveillance Study: Comparing Self-controlled Designs in Five Empirical Examples in Real-world Data |
| Q90654130 | Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer's Disease |
| Q55046512 | Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. |
Search more.